|
注册号: Registration number: |
ChiCTR1900020577 |
|
最近更新日期: Date of Last Refreshed on: |
2019-01-09 14:43:35 |
|
注册时间: Date of Registration: |
2019-01-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
NICU中新鲜与冷冻亲母母乳喂养早产儿的随机对照研究 |
|
Public title: |
A randomized controlled trial for comparing feeding preterm infants fresh versus frozen mother's own milk in the NICU |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
NICU中新鲜与冰冻亲母乳喂养<30周早产儿的随机对照研究 |
|
Scientific title: |
A randomized controlled trial for comparing feeding preterm infants <30 weeks' gestation fresh versus frozen mother's own milk in the NICU |
|
研究课题代号(代码): Study subject ID: |
FBM |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
孙慧清 |
研究负责人: |
李树锦 |
|
Applicant: |
Huiqing Sun |
Study leader: |
Shoo Lee |
|
申请注册联系人电话: Applicant telephone: |
+86 0371 85515913 |
研究负责人电话:
Study leader's |
+1 416 586-4800 ext 6370 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
s_huiqing@sina.com |
研究负责人电子邮件: Study leader's E-mail: |
Shoo.Lee@sinaihealthsystem.ca |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
河南省郑州市龙湖外环路33号 |
研究负责人通讯地址: |
多伦多大学600号 |
|
Applicant address: |
33 Waihuan Road, Longhu District, Zhengzhou, He'nan, China |
Study leader's address: |
600 University Avenue, Room 19-2310, Toronto, Ontario M5G 1X5 |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
郑州大学附属儿童医院 |
||
|
Applicant's institution: |
Children's Hospital affiliated to Zhengzhou University |
||
|
研究负责人所在单位: |
多伦多大学附属西奈山医院 |
||
|
Affiliation of the Leader: |
The Mount Sinai Hospital Affiliated to the University of Toronto |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2018042701 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
郑州大学附属儿童医院临床科研伦理委员会 |
||
|
Name of the ethic committee: |
Research Ethics Committee of Children’s Hospital affiliated to Zhengzhou University for Clinical Research |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
1990-01-01 00:00:00 | ||
|
伦理委员会联系人: |
和东阳 |
||
|
Contact Name of the ethic committee: |
Dongyang He |
||
|
伦理委员会联系地址: |
河南省郑州市龙湖外环路33号 |
||
|
Contact Address of the ethic committee: |
33 Waihuan Road, Longhu District, Zhengzhou, He'nan, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
中国新生儿协作网 |
||||||||||||||||||||||
|
Primary sponsor: |
Chinese Neonatal Network |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海儿童医学中心 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Shanghai Children Medical Center |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国新生儿协作网 |
||||||||||||||||||||||
|
Source(s) of funding: |
Chinese Neonatal Network |
||||||||||||||||||||||
|
研究疾病: |
新生儿坏死性小肠结肠炎和死亡率 |
||||||||||||||||||||||
|
Target disease: |
Neonatal necrotizing enterocolitis and motality |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
坏死性小肠结肠炎(NEC)是出生胎龄<30周的早产儿死亡的主要原因, 对于母乳喂养的早产儿,NEC的发病率比配方奶喂养的发病率低,目前我国多数早产儿是冷冻母乳或母乳巴氏消毒后喂养,但冷冻或巴氏灭菌会使母乳中有益的生物活性成分失活,降低有效性。 我们的初步研究表明,每天喂养一次新鲜亲母母乳安全可行,有降低NEC发生的趋势。 为了进一步探讨新鲜母乳喂养比冷冻母乳喂养对早产儿的有益性,采用多中心前瞻性随机对照试验进行每天2次的新鲜母乳喂养,以评估新鲜母乳喂养对早产儿发病率和病死率的影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
Necrotizing enterocolitis (NEC) is the leading cause of death among preterm infants born at <30 weeks’ gestation. The incidence of NEC is lower when infants are fed human milk, but freezing or pasteurization deactivates beneficial bioactive components of human milk. Our pilot study showed that one feed of fresh mother’s own milk per day was safe, feasible, and may reduce morbidity in preterm infants. To further evaluate the benefits of fresh human milk, a randomized controlled trial is needed. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.患儿有先天异常或接受姑息治疗的早产儿 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Infants with major congenital anomalies or receiving palliative care; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2019-01-01 00:00:00至 To 2021-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2019-01-01 00:00:00 至 To 2020-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
根据各家NICU 进行分层区组随机化,把患儿随机分配到对照组或新鲜母乳组,随机分配方案是按顺序编码、不透光、密封的信封的方法,应用随机分组软件产生分组顺序编码。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The statistician will create an allocation scheme for each site that will be concealed using sequentially numbered opaque sealed envelopes held by a research coordinator not involved with the study |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
未说明 |
|
Blinding: |
Not stated |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
试验未开始,无原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
We have no IPD yet |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
该研究采用病例记录表收集2019年1月1日至2020年12月31日关于母婴特征的数据,包括人口统计学,风险因素,分娩并发症,疾病严重程度评分,婴儿并发症,体重,生长和每日喂养方法,包括益生菌。所有信息都将收集在数据表格中,这些数据表格将输入到加密的Excel文件数据库中以供后续分析。所有数据都将被去除识别,我们将在汇总数据时使用患者编号而不是名称。数据访问将遵守隐私法规,所有数据将由研究专家委员会保存,以保护患者的隐私。上海复旦大学附属儿科医院研究所为母乳研究协调中心,协调中心将存储所有的研究数据和进行完整的数据分析。郑州大学附属儿童医院负责临床研究注册、各家医院伦理审查报告收集及研究数据的收集。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
We will collect data from January 1, 2019 to December 31, 2020 on maternal and infant characteristics including demographics, risk factors, delivery complications, illness severity scores, infant complications, weight, growth, and daily feeding practices, including probiotics. All information will be collected on data forms that will be entered into an encrypted excel file database for subsequent analysis. Study-specific variables will include compliance with the fresh milk protocol, the number and volume of fresh milk feeds provided to study infants on each day, and the response of the infant following the feed (Appendix 4). All data will be de-identified, and we will use patient numbers instead of names when summarizing data. Data access will comply with privacy regulations, and all data will be kept by a specialist to protect the patient’s privacy. The Research Institute of Children’s Hospital of Fudan University in Shanghai, China will host the coordinating center for the Fresh Milk study. The coordinating center will store all the study data and complete data analysis. Dr. Huiqing Sun from the Children’s Hospital affiliated to Zhengzhou University will be the Principal Investigator of the study and will be responsible for registering, receiving ethical approval, and notifying and receiving approval for changes to the study from the regulatory bodies. The study has received ethical approval from the ethics committee of the Children’s Hospital affiliated to Zhengzhou University for Clinical Research (REB #2018042701, Appendix 3). The study will be registered in the clinicaltrials.gov registry. To ensure ethical standards are met, we will obtain informed consent from each participating parent before enrollment and will respect the parents’ decision to join or leave the study at any time. Furthermore, we will use an incident reporting system that will be completed within 24 of an incident and will include a formal written report to guarantee patient’s safety. Finally, we will obtain parents’ written approval for publishing their names or pictures on the research update in addition to following the data privacy procedures described above. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |